Pfizer Inc. (PFE)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 158.72B |
| Enterprise value | 215.50B |
| Trailing P/E | N/A |
| Forward P/E | 12.85 |
| PEG ratio (5-yr expected) | 1.04 |
| Price/sales (ttm) | 2.88 |
| Price/book (mrq) | 1.72 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | N/A |
Trading information
Stock price history
| Beta (5Y monthly) | 0.58 |
| 52-week change 3 | -24.62% |
| S&P500 52-week change 3 | 26.27% |
| 52-week high 3 | 40.37 |
| 52-week low 3 | 25.20 |
| 50-day moving average 3 | 26.98 |
| 200-day moving average 3 | 30.03 |
Share statistics
| Avg vol (3-month) 3 | 42.44M |
| Avg vol (10-day) 3 | 54.39M |
| Shares outstanding 5 | 5.67B |
| Implied shares outstanding 6 | 5.7B |
| Float 8 | 5.66B |
| % held by insiders 1 | 0.05% |
| % held by institutions 1 | 70.30% |
| Shares short (15 Apr 2024) 4 | 68.06M |
| Short ratio (15 Apr 2024) 4 | 1.83 |
| Short % of float (15 Apr 2024) 4 | 1.20% |
| Short % of shares outstanding (15 Apr 2024) 4 | 1.20% |
| Shares short (prior month 15 Mar 2024) 4 | 71.65M |
Dividends & splits
| Forward annual dividend rate 4 | 1.68 |
| Forward annual dividend yield 4 | 6.00% |
| Trailing annual dividend rate 3 | 1.65 |
| Trailing annual dividend yield 3 | 5.86% |
| 5-year average dividend yield 4 | 4.02 |
| Payout ratio 4 | 443.24% |
| Dividend date 3 | 14 Jun 2024 |
| Ex-dividend date 4 | 09 May 2024 |
| Last split factor 2 | 1054:1000 |
| Last split date 3 | 17 Nov 2020 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | -0.56% |
| Operating margin (ttm) | 31.63% |
Management effectiveness
| Return on assets (ttm) | 0.93% |
| Return on equity (ttm) | -0.26% |
Income statement
| Revenue (ttm) | 54.89B |
| Revenue per share (ttm) | 9.72 |
| Quarterly revenue growth (yoy) | -19.50% |
| Gross profit (ttm) | N/A |
| EBITDA | 9.62B |
| Net income avi to common (ttm) | -288M |
| Diluted EPS (ttm) | -0.05 |
| Quarterly earnings growth (yoy) | -43.80% |
Balance sheet
| Total cash (mrq) | 11.93B |
| Total cash per share (mrq) | 2.11 |
| Total debt (mrq) | 69.9B |
| Total debt/equity (mrq) | 75.52% |
| Current ratio (mrq) | 1.05 |
| Book value per share (mrq) | 16.28 |
Cash flow statement
| Operating cash flow (ttm) | 8.58B |
| Levered free cash flow (ttm) | 3.46B |
© 2024 Yahoo. All rights reserved.